IPO Premiums
IPO calendar
KLListed

Kronox Lab Sciences Limited

Book Built Issue IPO · NSE, BSE

Price band
₹129 - ₹136
Lot size
110 shares
Issue amount
₹130.15 cr
Total subscription
117.25×
Current price₹186.14
Listing price ₹164.95
Watch live price ↗
Opens
3 Jun 2024
Closes
5 Jun 2024
Allotment
6 Jun 2024
Listing
10 Jun 2024

Offer at a glance

Issue overview

Issue size
95,70,000 shares
Face value
₹10 Per Equity Share
Minimum investment
₹14,190
Fresh issue
₹0 cr
Offer for sale
₹130.15 cr
Registrar
Kfin Technologies Limited
Listing exchange
NSE, BSE
Maximum investment
₹14,960
Issue type
Book Built Issue IPO
Shares before issue
3,71,04,000
Shares after issue
3,71,04,000

Lot sizes

CategoryLotsSharesAmount
RETAIL1110₹14,960
sHNI141,540₹2,09,440
bHNI677,370₹10,02,320

Share reservation

Retail35%
NII(HNI)15%
QIB20%

Subscription & GMP

Subscription by category

Total subscribed117.25×

Missing multiples are calculated from bids and offered shares when available.

QIB89.03×
NIB301.91×
HNIs(10L +)322.26×
HNIs (2-10L)261.22×
RETAIL54.23×

GMP history

014287 Mar: ₹2814 Nov: ₹2815 Nov: ₹2817 Nov: ₹2826 Nov: ₹28
7 Mar₹2826 Nov

Application-wise demand

CategoryReserved applicationsApplied applications
HNIs(10L +)62140,181
HNIs (2-10L)31178,159
RETAIL30,45014,11,824

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
QIBs26.032,317.57
RETAIL45.552,470.31
HNIs 2+6.511,699.89
HNIs 10+13.024,194.33

Financial performance

Company financials

In Crores · Reported periods may include interim results.

Revenue & profit In Crores
050100Mar-21 · Revenue: 63.24Mar-21 · Profit after tax: 9.73Mar-21Mar-22 · Revenue: 83.34Mar-22 · Profit after tax: 13.63Mar-22Mar-23 · Revenue: 97.5Mar-23 · Profit after tax: 16.62Mar-23Dec-23 · Revenue: 68.44Dec-23 · Profit after tax: 15.47Dec-23
RevenueProfit after tax

Key performance indicators

MetricDec-23Mar-23Mar-22
EPS4.174.33.49
ROE25.6637.1933.77
ROCE33.1533.549.86
RONW25.6637.1933.77
PRE IPO(PE)8.3700
POST IPO(PE)30.3700

Values and labels as reported in the issue data.

Company information

Company profile

Kronox Lab Sciences Limited, founded in 2008, is a leading manufacturer of high-purity speciality chemicals used in various industries like pharmaceuticals, biotech, agrochemicals, personal care, and animal health. The company offers 185+ products such as phosphate, sulphate, chloride, and EDTA derivatives, serving customers in India and over 20 countries including the USA, Australia, UK, and China. Kronox operates three manufacturing units in Vadodara, Gujarat with a total capacity of 7,242 TPA. Their facilities follow strict quality standards with certifications like ISO, FSSC, Kosher, Halal, GMP, and GLP. The company focuses heavily on research and development, working on 122 new products and serving 592+ customers in the last three years, with many returning for repeat orders.

Strengths

  • Wide Product Range and Versatile Uses: Kronox Lab Sciences Limited provides 185+ high-purity speciality fine chemicals used in pharmaceuticals, nutraceuticals, biotech, agrochemicals, personal care, metal refineries, and animal health industries.
  • Strong Customer Bonds: The company serves 592+ customers , out of which 141 customers place repeat orders , showing customer trust and satisfaction .
  • Tough Market Entry & Exit: Strict product quality standards and lengthy customer approval processes make it difficult for new competitors to enter or exit the market , helping Kronox maintain a strong market position .

Risk factors

  • Strict Industry Standards Compliance: If the company doesn't follow domestic and international industry standards, customers may reject the products, which could harm the company's reputation.
  • Dependence on Third-Party Logistics: The company relies on outside logistics providers for transportation. This could lead to delays, higher costs, theft, accidents, or product loss during delivery, affecting business operations and profits.
  • High P/E Ratio: The company’s stock is priced much higher than the industry average, which could be risky if the market shifts or if the company fails to meet its growth expectations.

Promoters

Jogindersingh Jaswal

Ketan Ramani

Pritesh Ramani

Registrar & documents

Lead manager

Pantomath Capital Advisor Private Limited

Registered office

Block No. 353, Village Ekalbara, Padra, Vadodara-391440

+91 26 6224 4077/88

[email protected]Company website ↗

Frequently Asked Questions

What is Kronox Lab Sciences IPO GMP today?

As of today, Kronox Lab Sciences IPO Grey Market Premium (GMP) is reported at +₹28 per share. Based on the upper price band of ₹136, the estimated listing price is ₹164 (+20.6% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.

What is the lot size and minimum investment for Kronox Lab Sciences IPO?

The minimum bid lot size for Kronox Lab Sciences IPO is 110 shares. At the cut-off price of ₹136 per share, retail investors need a minimum application amount of ₹14,960 per lot. Retail applicants can apply for a maximum of 13 lots (up to ₹2,00,000).

When will Kronox Lab Sciences IPO allotment status be announced?

The allotment status for Kronox Lab Sciences IPO is scheduled to be finalized on 6 Jun 2024. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Kfin Technologies Limited's official portal or via BSE/NSE allotment portals.

How can I check Kronox Lab Sciences IPO allotment status online by PAN?

To check Kronox Lab Sciences IPO allotment status: 1) Visit the registrar portal (Kfin Technologies Limited) or the BSE IPO allotment page. 2) Select 'Kronox Lab Sciences Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.

Explore More IPO Analysis & Live Tools

Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.

Regulatory Disclaimer: Grey Market Premium (GMP) is an unofficial, unregulated indicator of market sentiment and does not represent a stock exchange transaction, guarantee, or investment advice. IPO Premiums is an informational and research portal and is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before applying for any IPO.